Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Buzz on the Bullboards: Despite energy woes, TSX hits new high

This week, the TSX endured fluctuations but ultimately achieved a new high in intraday trading. The tech sector has been a significant driver of these gains, thanks to a solid performance among top stocks in the sector. One of Canada’s leading te...
Jonathon Brown | October 10, 2024 |

Buzz on the Bullboards: Stocks to watch as TSX hits new highs

This week, the TSX experienced a roller-coaster of wins and losses, yet managed to break a record high. In the face of this dynamic trading environment, three companies have stood out for their notable achievements and promising outlooks. When the Clevela...
Jonathon Brown | October 17, 2024 |

IVERIC bio Shares Double After Announcing Phase 2b AMD Topline Data

Shares of IVERIC bio opened nearly 100% higher today after reporting that it successfully met its primary endpoint in its Phase 2b age-related macular degeneration study for Zimura. Early this morning, gene therapy focused biopharmaceutical company IVERIC bio Inc. (I...
Streetwise Reports | October 29, 2019 |

Will U.S. Shale Survive If Oil Hits $40?

Within a month, the U.S. oil benchmark West Texas Intermediate recorded two first-of-a-kind events. First, it fell below zero on April 20. Then, it soared up so high it is about to book its best month ever, CNBC's Pippa Stevens noted in a recent commentary. Still, many ...
Irina Slav | May 28, 2020 |

Gold vs cash in a crisis

Mattress stuffers or bullion holders? Who fares better in a crisis? North American investors are divided between those who believe the decade-long stock market bull is going to keep running into the 2020s, and investors who, wary of something terrible happening, are hoarding...
Richard (Rick) Mills | December 20, 2019 |

White Gold Hits Gold Bigly

I called for a pop in the price of White Gold Corp. (WGO:TSX.V; WHGOF:OTCMKTS) when I wrote about them two weeks ago . We got it. The shares were $0.77 when I wrote and went as high at $0.99 in short order. I compared WGO to Great Bear and in my view stated that I ...
Streetwise Reports | November 27, 2019 |

Baltic Dry, Copper, Oil, Tech and China Continue to Call for Market Crash Soon

Technical analyst Clive Maund takes a hard look at various charts and sees an impending breakdown of commodity and tech markets. In this update we are going to review a small but important range of commodities and lead indicators that strongly suggest the seemingly...
Streetwise Reports | February 19, 2020 |

ROCK hits high VMS grades in first five holes

Rockridge Resources (TSX-V:ROCK) is off to a flying start at its Knife Lake volcanogenic massive sulfide (VMS) deposit in Saskatchewan, with the first five holes of its 2019 drill campaign returning high-grade copper-gold-zinc-cobalt mineralization. The company is aiming t...
Richard (Rick) Mills | May 10, 2019 |

Ardelyx's Shares Soar 65% as Tenapanor Phase 3 Study Hits the Mark

Clinical-stage specialized biopharmaceutical company Ardelyx announced positive results today for its phase 3 AMPLIFY study for tenapanor aimed at improving treatment for cardiorenal diseases. This morning clinical-stage biopharmaceutical developer of medicines for th...
Streetwise Reports | September 4, 2019 |

Producer Hits 'Major' Discovery, Target Price Raised

This new finding of SilverCrest Metals and its potential to improve the upcoming project feasibility study are described in a ROTH Capital Partners report. In a Feb. 18 research note, ROTH Capital Partners analyst Jake Sekelsky reported that SilverCrest Met...
Streetwise Reports | February 25, 2020 |
1 2 3 4 5 6 7 8 9 10 ...